Antidepressant Drugs Flashcards
1
Q
citalopram
A
- SSRI
- selectively inhibit pre-synaptic reuptake of 5-HT
- LITTLE EFFECT on histamine, muscarinic, or adrenergic receptors
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
2
Q
escitalopram
A
- SSRI
- selectively inhibit pre-synaptic reuptake of 5-HT
- LITTLE EFFECT on histamine, muscarinic, adrenergic receptors, or CYP450
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
3
Q
fluoxetine
A
- SSRI
- selectively inhibit pre-synaptic reuptake of 5-HT
- INHIBITS CYP450
- LITTLE EFFECT on histamine, muscarinic, or adrenergic receptors
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
4
Q
paroxetine
A
- SSRI
- selectively inhibit pre-synaptic reuptake of 5-HT
- LITTLE EFFECT on histamine, muscarinic, or adrenergic receptors
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
5
Q
sertraline
A
- SSRI
- selectively inhibit pre-synaptic reuptake of 5-HT
- LITTLE EFFECT on histamine, muscarinic, or adrenergic receptors
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
6
Q
vilazodone
A
- SSRI
- selectively inhibit pre-synaptic reuptake of 5-HT
- ALSO a partial agonist at 5-HT1a receptor
- LITTLE EFFECT on histamine, muscarinic, or adrenergic receptors
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
7
Q
vortioxetine
A
- SSRI
- selectively inhibit pre-synaptic reuptake of 5-HT\
- ALSO a partial agonist at 5-HT1b, and a FULL agonist at 5-HT1a and 5-HT1d3,7 receptors
- LITTLE EFFECT on histamine, muscarinic, adrenergic receptors, or CYP450
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns
8
Q
amitryptyline
A
- TCA and SNRI
- 3° amine (inhibit NE<5-HT)
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- risk of coma, cardiotoxicity, convulsions
9
Q
clomipramine
A
- TCA and SNRI
- 3° amine (inhibit NE<5-HT)
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- risk of coma, cardiotoxicity, convulsions
10
Q
doxepin
A
- TCA and SNRI
- 3° amine (inhibit NE/5-HT equally)
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- risk of coma, cardiotoxicity, convulsions
11
Q
imipramine
A
- TCA and SNRI
- 3° amine (inhibit NE/5-HT equally)
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- used for ENURESIS
- risk of coma, cardiotoxicity, convulsions
12
Q
amoxapine
A
- TCA and SNRI
- 2° amine (inhibit NE>5-HT)
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- risk of coma, cardiotoxicity, convulsions
13
Q
desipramine
A
- TCA and SNRI
- 2° amine (inhibit NE>5-HT)
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- risk of coma, cardiotoxicity, convulsions
14
Q
nortriptyline
A
- TCA and SNRI
- 2° amine (inhibit NE>5-HT)
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- risk of coma, cardiotoxicity, convulsions
15
Q
desvenlafaxine
A
- SNRI
- selectively inhibit pre-synaptic reuptake of 5-HT and norepinephrine
- risk of SUICIDE, SEROTONIN SYNDROME, CNS depression, decreased libido, weight gain, ACUTE withdrawal rxns